Bottom line
How much do FACDX and QAAGZX overlap?
47% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 40.0% of FACDX's assets and 46.1% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FACDX and QAAGZX have in common
| Holding | % of FACDX | % of QAAGZX | Overlap |
|---|---|---|---|
| ELI LILLY and CO | 7.66% | 14.06% | 7.66% |
| Danaher Corp | 6.75% | 1.44% | 1.44% |
| Thermo Fisher Scientific Inc | 6.31% | 2.53% | 2.53% |
| Unitedhealth Group Inc | 4.17% | 5.88% | 4.17% |
| JOHNSON and JOHNSON | 3.78% | 6.64% | 3.78% |
| Abbvie Inc | 3.62% | 5.12% | 3.62% |
| MERCK and CO INC | 2.09% | 4.00% | 2.09% |
| Natera Inc | 1.65% | 1.44% | 1.44% |
| Guardant Health Inc | 1.48% | 1.22% | 1.22% |
| Cvs Health Corp | 1.29% | 0.93% | 0.93% |
| Gilead Sciences Inc | 1.25% | 2.79% | 1.25% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FACDX
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
- Ascendis Pharma A/s — 1.95%
- Alnylam Pharmaceuticals Inc — 1.78%
- Agilent Technologies Inc — 1.75%
- Viatris Inc — 1.67%
- 10x Genomics Inc — 1.45%
- Revolution Medicines Inc — 1.44%
- Waters Corp — 1.43%
- Oruka Therapeutics Inc — 1.32%
- Ucb Sa — 1.32%
- Boston Scientific Corp — 1.23%
- Repligen Corp — 1.22%
Only in QAAGZX
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
- Intuitive Surgical Inc — 1.89%
- Amgen Inc — 1.80%
- Stryker Corp — 1.78%
- Elevance Health Inc — 1.54%
- Cardinal Health Inc — 1.04%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- T. Rowe Price Government Reserve Fund — 0.87%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
Asset mix
| Asset type | FACDX | QAAGZX |
|---|---|---|
| Stocks | 97.7% | 96.9% |
| Cash & short-term funds | 2.8% | 0.9% |
| Preferred stock | 2.1% | 2.2% |
| Bonds | 0.2% | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | FACDX | QAAGZX |
|---|---|---|
| US | 88.0% | 92.3% |
| NL | 2.9% | 1.0% |
| GB | 2.6% | 1.8% |
| DK | 2.0% | 0.7% |
| BE | 1.3% | — |
| KY | 1.3% | 0.5% |
| BM | 1.0% | 0.7% |
| IE | 1.0% | 0.8% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FACDX and QAAGZX overlap?
What stocks do FACDX and QAAGZX have in common?
Should I own both FACDX and QAAGZX?
Which holds more stocks, FACDX or QAAGZX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.